Updates to the Controlled Substance Act, Effective January 1, 2012

Added Drugs to Controlled Substance List
II. Tapentadol, Lisdexamfetamine (720 ILCS 570/206)
III. Aprobarbital, Butabarbital, Butalbital, Butobarbital, Thiopental, Buprenorphine (720 ILCS 570/207)
IV. Carisoprodol, Dichloralphenazone, Fospropofol, Tramadol, Zopiclone (720 1LCS 570/209)
V. Ezogabine, Lacosamide, Pregabalin (720 ILCS 570/211)

Electronic Prescriptions
(720 ILCS 570/311.5) Click on Link for more information.

Electronic prescriptions for controlled substances. Notwithstanding any other Section in this Act, a prescriber who is otherwise authorized to prescribe controlled substances in Illinois may issue an electronic prescription for Schedule II, III, IV, and V controlled substances if done in accordance with the federal rules for electronic prescriptions for controlled substances, as set forth in 21 C.F.R. Parts 1300, 1304, 1306, and 1311.

3 Sequential 30-day Prescriptions for Schedule II
(720 ILCS 570/312) Click on Link for more information.

(a-5) Physicians may issue multiple prescriptions (3 sequential 30-day supplies) for the same Schedule II controlled substance, authorizing up to a 90-day supply. Before authorizing a 90-day supply of a Schedule II controlled substance, the physician must meet both of the following conditions:
  1. Each separate prescription must be issued for a legitimate medical purpose by an individual physician acting in the usual course of professional practice.
  2. The individual physician must provide written instructions on each prescription (other than the first prescription, if the prescribing physician intends for the prescription to be filled immediately) indicating the earliest date on which a pharmacy may fill that prescription.

Reporting Discharge Medication
(720 ILCS 570/313) Click on the Link for more information.

Controlled drug discharge medication greater than a 72-hour supply must be reported to the Illinois PMP.

Mailing of Controlled Substances
(k) Controlled substances may be mailed if all of the following conditions are met:
  1. The controlled substances are not outwardly dangerous and are not likely, of their own force, to cause injury to a person's life or health.
  2. The inner container of a parcel containing controlled substances must be marked and sealed as required under this Act its rules, and be placed in a plain outer container or securely wrapped in plain paper.
  3. If the controlled substances consist of prescription medicines, the inner container must be labeled to show the name and address of the pharmacy or practitioner dispensing the prescription.
  4. The outside wrapper or container must be free of markings that would indicate the nature of the contents.
Medication Shopping, Pharmacy Shopping, and Unsolicited Reporting
(720 ILCS 570/314.5) Click on Link for more information.

It shall be unlawful for any person knowingly or intentionally to fraudulently obtain or fraudulently seek to obtain any controlled substance or prescription for a controlled substance from a prescriber or dispenser while being supplied with any controlled substance or prescription for a controlled substance by another prescriber or dispenser, without disclosing the fact of the existing controlled substance or prescription for a controlled substance to the prescriber or dispenser from whom the subsequent controlled substance or prescription for a controlled substance is sought.

When a patient is identified as hitting a predefined threshold of multiple prescription and multiple prescribers, the PMP may issue an unsolicited report to the prescribers informing them to the potential medication shopping.

Additional Reporting Fields for the Prescription Monitoring Program
(720 ILCS 570/316) Click on Link for more information.

Date Filled, Payment Type (Medicaid, Cash, Insurance, etc...), Patient Location Code, etc...

Long-Term Care Medication Management
(c) The collection of data on select drugs and scheduled substances by the Prescription Monitoring Program may be used as a tool for addressing oversight requirements of long-term care institutions as set forth by Public Act 96-1372. Long-term care pharmacies shall transmit patient medication profiles to the Prescription Monitoring Program monthly or more frequently as established by administrative rule.